IITKanpur develops ‘Sanjeevani’ oxygen concentrator, transfers manufacturing technology to Bengaluru firm
Kanpur | IIT Kanpur has developed an advanced Oxygen Concentrator equipped with PSA (Pressure Swing Adsorption) Technology in order to reach the commercial scale so that the benefit could be transferred to the public at large. The technology has now been transferred and licensed to a Bengaluru based company – Albot Technologies Private Limited.
An MoU Exchange ceremony was held virtually to transfer oxygen concentrator development technology to Albot Technologies. This ceremony was attended by IITK Director, Professor Abhay Karandikar and CEO of Albot Technologies, Akash Singh.
Oxygen Concentrator ‘Sanjeevani’ has been developed by IITKanpur anticipating the third wave of COVID pandemic. The concentrator has been developed by a team involving Professor J. Ramkumar from Department of Mechanical Engineering, Siddhanth Srivastava PhD student, Jitendra Kumar, Dr Amandeep Singh Oberoi, Rupendra Aryal and Nitin Chaukhat.
SPONSORED CONTENT
The oxygen concentrator works at a flow rate of 10 LPM with an oxygen purity of approx 92%. The concentrator has an adjustable capacity of 1 to 10 LPM, which can be used for both medical as well as personal uses.
During the ceremony Professor Karandikar briefed the gathering about the several ongoing projects at IIT-Kanpur. He also apprised them about the ongoing progress of School of Medical Research and Technology at IIT-Kanpur which will house 400 patient bed hospital in the campus and emphasized that R&D activity of the school shall promote research leading to development of innovative and cost effective medical devices.
Professor In-Charge of Innovation at IIT Kanpur Professor Amitabha Bandyopadhyay mentioned that the incubator of IIT Kanpur is actively working with several stakeholders for expediting the medical device development ecosystem in the country including Yamuna expressway development authority and some international partners.
By EP Web Desk
The English Post is on Telegram, click to join for regular news updates
SPONSORED CONTENT
